Blood samples
Blood samples is an intervention with 315 clinical trials. Currently 64 active trials ongoing. Historical success rate of 87.2%.
Success Metrics
Based on 150 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
7
Mid Stage
18
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
82.9%
150 of 181 finished
17.1%
31 ended early
64
trials recruiting
315
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity
Extracellular RNA Markers of Liver Disease and Cancer
TocilizuMab discontinuAtion in GIant Cell Arteritis
Molecular Analysis of Endoscopic Cytology Samples Supernatant in Pulmonary Nodules
Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients
Clinical Trials (315)
Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity
Extracellular RNA Markers of Liver Disease and Cancer
TocilizuMab discontinuAtion in GIant Cell Arteritis
Molecular Analysis of Endoscopic Cytology Samples Supernatant in Pulmonary Nodules
Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients
MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial
Oral Aromatase Inhibitors Modify the Gut Microbiome
PWS European Blood Bank for Infants and Controls From 0 to 48 Months
Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer Patients
Adherence to Oral Therapies in Advanced Breast and Prostate Cancers
Monitoring of Donor-specific Antibodies After Treatment With Immunoglobulins, Plasmapheresis and Rituximab in Lung Transplantation
New Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase δ Syndrome
Study in Leptomeningeal Metastases of Breast Cancer
Kinetics of Plasma and Serum Levels of Brain-Derived Neurotrophic Factor (BDNF) in Patients With Ischemic Stroke
Calprotectin, a Biomarker of COVID-19 Severity (CALPRO)
Mesenteric Ischemia Markers Study
Personalised Pharmacological Approach to the Tapering of Corticosteroid Doses in Systemic Lupus Patients Treated With Prednisone
Iron Deficiency (ID) in Infants
Prospective Data Collection Initiative on Thoracic Malignancies
Trauma Exposure and Suicidal Behaviors in Adolescents Aged 11-17 Hospitalized in Child and Adolescent Psychiatry
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 315